Marshall Smith Syndrome
Marshall Smith Syndrome
National Organization for Rare Disorders, Inc.
It is possible that the main title of the report Marshall Smith Syndrome is not the name you expected. Please check the synonyms listing to find the alternate name(s) and disorder subdivision(s) covered by this report.
Related Disorders List
Information on the following diseases can be found in the Related Disorders section of this report:
- Weaver Syndrome
- Sotos Syndrome
- McCune-Albright Syndrome
Marshall-Smith Syndrome is characterized by unusually quick physical growth and bone development (maturation), usually starting before birth. Other symptoms can include respiratory difficulties, mental retardation, and certain physical characteristics. (Note: Marshall-Smith Syndrome is not to be confused with "Marshall" Syndrome, which is very different from "Marshall-Smith" Syndrome.)
In patients with Marshall-Smith Syndrome growth and bone development (maturation) occur faster than normal. The individual is underweight in relation to his or her height and does not thrive well. Other symptoms include diminished muscle tone (hypotonia), muscle weakness, hernias in the abdomen (umbilical hernias), and/or mental retardation. Slow development of voluntary movements (psychomotor retardation) may also occur.
Breathing (respiratory) difficulties commonly occur in patients with Marshall-Smith Syndrome. High-pitched noisy breathing which sounds similar to the wind blowing (stridor), extension of the neck beyond normal limits (hyperextension), or the tongue obstructing the air passage may occur.
Physical characteristics of Marshall-Smith Syndrome include excessive hair growth (hypertrichosis), a long head with a prominent forehead, prominent eyes, and/or an upturned nose with a low nasal bridge. The white of the eye (sclerae) may appear bluish. The angle of the lower jawbone on each side of the face as it joins in the front to form the chin (mandibular ramus) may be smaller than average. Generally, the bones of the fingertips (distal phalanges) are narrow but the rest of the bones in the fingers (proximal and middle phalanges) are broad.
Infrequently, the leaf-shaped structure in the throat which normally prevents food or liquid from passing into the windpipe (epiglottis) may not develop properly in some patients with Marshall-Smith Syndrome. Absent and/or smaller than normal openings leading from the nasal passages into the post-nasal space (choanal atresia and/or stenosis), an abnormal larynx and/or soft cartilage of the larynx (laryngomalacia), a short breastbone (sternum), or a deep crease between the big toe (hallux) and second toe may occur in some patients.
Occasionally, brain abnormalities such as atrophy (cerebral atrophy), larger than normal convolutions of the cerebral cortex (macrogyria), or an absent corpus collosum may occur. (For more information on absence of the corpus collosum, choose "corpus collosum" as your search term in the Rare Disease Database). Defects in the immune system (immunologic defect) are sometimes present. Although rare, some babies with Marshall-Smith Syndrome are born with a sac containing part of the intestines protruding outside the abdominal wall, with the umbilical cord attached (omphalocele).
The exact cause of Marshall-Smith Syndrome is unknown. There is no evidence that it is genetic.
Marshall-Smith Syndrome is a rare disorder present at birth affecting males and females in equal numbers. Symptoms of the syndrome are usually present before birth (prenatal onset).
Weaver Syndrome is similar to Marshall-Smith Syndrome in that growth and bone maturation occur faster than normal. However, patients with Weaver Syndrome have normal to above normal weight in relation to their height whereas patients with Marshall-Smith Syndrome are underweight in relation to their height. There are other differences as well. For example, Marshall-Smith Syndrome patients have different physical characteristics, respiratory difficulties, and other symptoms that patients with Weaver Syndrome do not have. (For more information on Weaver Syndrome, choose "Weaver" as your search term in the Rare Disease Database.)
Gigantism occurs before puberty and is caused by oversecretion of growth hormone. It is characterized by excessive growth during childhood with relatively normal body proportions and sexual development. Height sometimes reaches 7 or 8 feet. Soft tissues are also enlarged. In extreme cases, disease of muscle tissue (myopathy) and abnormalities of nerves distant from the brain and spinal cord (peripheral neuropathy) may occur. Certain hereditary syndromes such as Klinefelter Syndrome, Marfan Syndrome, and some of the lipodystrophies, may include tallness among their symptoms. (For more information choose "gigantism, ""giant," or "peripheral neuropathy" as your search term in the Rare Disease Database.)
Soto's Syndrome is a rare, hereditary disorder characterized by excessive growth (over the 90th percentile) during the first 4 to 5 years of life. Abnormalities of the nervous system, including aggressiveness, irritability, clumsiness, an awkward gait, and mental retardation sometimes also occur. Physical characteristics also include eyes which appear to be abnormally far apart (hypertelorism) and slanted. (For more information, choose "Soto" as your search term in the Rare Disease Database.)
McCune-Albright Syndrome (Osteitis Fibrosa Disseminata) is characterized by an early (precocious) sexual development, a change in bone integrity which produces pain, increasing deformity and disability, and possible changes in skin pigmentation. This syndrome involves the endocrine, muscle and bone systems. Excessive secretion of growth hormone as well as other hormones occurs in some cases. Children with McCune-Albright Syndrome are excessively tall during childhood, but their growth stops early and they usually don't reach normal height during adulthood. (For more information, choose "McCune-Albright" as your search term in the Rare Disease Database.)
Treatment of Marshall-Smith Syndrome is symptomatic and supportive. Aggressive treatment of breathing (respiratory) difficulties is necessary. Special education and related services will be necessary during school years.
Information on current clinical trials is posted on the Internet at www.clinicaltrials.gov. All studies receiving U.S. government funding, and some supported by private industry, are posted on this government web site.
For information about clinical trials being conducted at the NIH Clinical Center in Bethesda, MD, contact the NIH Patient Recruitment Office:
Tollfree: (800) 411-1222
TTY: (866) 411-1010
For information about clinical trials sponsored by private sources, contact:
Smith's Recognizable Patterns of Human Malformation, 5th Ed.: Kenneth Lyons Jones, M.D.; W.B. Saunders Co., 1997. Pp. 162-163.
Marshall-Smith Syndrome: Case Report of a Newborn Male and Review of the Literature. D. A. Summers, et al., Clin Dysmorphol. (Jul 1999, 8 (3)). Pp. 207-10.
Anaesthetic Management of a Child with Marshall-Smith Syndrome. G. Dernedde, et al., Can J Anaesth. (Jul 1998, 45 (7)). Pp. 660-63.
Neonatal Death in Marshall-Smith Syndrome. C. Chatel, et al., Genet Couns. (1998,
9 (1)). Pp. 15-18.
Long Survival of a Patient with Marshall-Smith Syndrome without Respiratory Complications. D. Sperli, et al., J Med Genet. (Oct 1993, 30 (10)).
Marshall-Smith Syndrome: New Radiograhic, Clinical and Pathological Observations. G. F. Eich et al., Radiology, (Oct 1991, 181 (1)). Pp. 183-188.
FROM THE INTERNET
www.orpha.net/static/GB/marshallsmith_syndrome.html - 48k
Human Growth Foundation
997 Glen Cove Avenue
Glen Head, NY 11545
6645 W. North Avenue
Oak Park, IL 60302
Little People of America, Inc.
250 El Camino Real Suite 201
Tustin, CA 92780
Coalition for Heritable Disorders of Connective Tissue (CHDCT)
4301 Connecticut Avenue, NW Suite 404
Washington, DC 20008
Genetic and Rare Diseases (GARD) Information Center
PO Box 8126
Gaithersburg, MD 20898-8126
MSS Research Foundation (Marshall-Smith Syndrome)
The Hague, NL 2548 WP
For a Complete Report
This is an abstract of a report from the National Organization for Rare Disorders, Inc.® (NORD). Cigna members can access the complete report by logging into myCigna.com. For non-Cigna members, a copy of the complete report can be obtained for a small fee by visiting the NORD website. The complete report contains additional information including symptoms, causes, affected population, related disorders, standard and investigational treatments (if available), and references from medical literature. For a full-text version of this topic, see http://www.rarediseases.org/search/rdblist.html.
The information provided in this report is not intended for diagnostic purposes. It is provided for informational purposes only. NORD recommends that affected individuals seek the advice or counsel of their own personal physicians.
It is possible that the title of this topic is not the name you selected. Please check the Synonyms listing to find the alternate name(s) and Disorder Subdivision(s) covered by this report
This disease entry is based upon medical information available through the date at the end of the topic. Since NORD's resources are limited, it is not possible to keep every entry in the Rare Disease Database completely current and accurate. Please check with the agencies listed in the Resources section for the most current information about this disorder.
For additional information and assistance about rare disorders, please contact the National Organization for Rare Disorders at P.O. Box 1968, Danbury, CT 06813-1968; phone (203) 744-0100; web site www.rarediseases.org or email firstname.lastname@example.org
Last Updated: 8/8/2007
Copyright 1990, 1999, 2007 National Organization for Rare Disorders, Inc.
Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.